Battelle Neural Bypass Technology Restores Movement to a Paralysed Man's Arm and Hand
15 October, 2025 by Stéphane Marouani, Country Manager A/NZ at MathworksBattelle has developed a technology that bypasses damaged neural pathways, enabling a quadriplegic man to regain control of his right forearm, hand and fingers.
Low-dose drug prevents diabetes progression in young people
10 October, 2025A low dose of the immunomodulatory drug anti-thymocyte globulin (ATG) appears safe and effective in preventing progression of type 1 diabetes in young people.
Common arthritis drug also lowers blood pressure
10 September, 2025Scientists have known for a while that methotrexate helps with inflammation, but it may also help lower blood pressure, which is a major risk factor for heart disease.
Liquid fat treatment provides hope for rare childhood disease
22 August, 2025A liquid fat supplement, triheptanoin, can reverse mitochondrial dysfunction and cell death in patients with the degenerative disease known as Ataxia–telangiectasia.
NSW Govt delivers foot-and-mouth vaccine to protect livestock
20 August, 2025A biodegradable vaccine to protect livestock from foot-and-mouth disease has been developed as part of a research partnership between Meat & Livestock Australia, Tiba Biotech and the NSW Government.
Scientists optimise delivery of mRNA to target cells
19 August, 2025A highly versatile new method captures and attaches antibodies to the surface of mRNA-loaded lipid nanoparticles while the antibodies are in their optimal orientation, thus enhancing the mRNA’s effectiveness.
HIV drugs suppress transmission of a different viral infection
05 August, 2025The work could lead to the first treatments to prevent the spread of the life-threatening HTLV-1 virus, which is endemic among many First Nations communities around the world.
Oral drug shows promise for treating Barth syndrome
24 July, 2025An oral drug called MA-5 can improve both heart and muscle problems in Barth syndrome, a rare genetic disorder affecting one in 300,000 births worldwide.
Novel drug candidates found for nerve pain and ischemic disease
09 July, 2025The discovery paves the way for potential new treatments for health conditions linked to tissue stress and inflammation, without accompanying side effects.
Biomaterial helps to reverse aging in the heart
24 June, 2025The discovery could open the door to therapies that rejuvenate the heart by changing its cellular environment, rather than the heart cells themselves.
Anti-inflammatory agent could decrease septic shock mortality
20 June, 2025Researchers have discovered a naturally occurring blood protein — a type of corticosteroid-binding globulin (CBG) — that could significantly decrease mortality caused by septic shock.
mRNA used to force HIV out of hiding
17 June, 2025Using the same technology behind mRNA COVID-19 vaccines, researchers have discovered a way to deliver mRNA to the elusive HIV reservoir and coax HIV out of hiding.
TGA approves therapy for paediatric growth hormone deficiency
11 June, 2025The TGA has approved SKYTROFA as a treatment for growth failure in children and adolescents aged from 3–18 years due to insufficient endogenous growth hormone secretion.
WMFTS WMArchitect Interchangeable Parts service for single-use assemblies
10 June, 2025Watson-Marlow Fluid Technology Solutions (WMFTS) has introduced WMArchitect Interchangeable Parts to secure a resilient supply of single-use assemblies by including pre-qualified, alternative components in the design stage to avoid regulatory compliance interruptions and long lead times.
Contact lens breakthrough lets humans see infrared light
29 May, 2025Newly created contact lenses enable infrared vision in both humans and mice by converting infrared light into visible light — which could transform medical imaging and visual assistance technologies.
